Tectonic Therapeutic | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Adcock Ingram Holdings ZAR 487.33M 8.25M 2024-12
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Celltrion KRW 242.47B 94.87B 2025-06
Cspc Pharmaceutical CNY 1.79B 940.51M 2025-03
Dianthus Therapeutics USD -34927000 3.01M 2025-06
Divis Laboratories Ltd 6.17B 1.62B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Kangmei Pharma CNY 16.43M 3.34M 2025-06
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 27.37M 95.7M 2025-06
MacroGenics USD -36760000 20.17M 2025-06
Malin Corporation EUR -1100000 400K 2024-12
Medical Developments International AUD 182K 20.42M 2024-12
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -2100000 9.2M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Pharma Mar EUR 24.11M 27.19M 2025-06
Qiagen NV USD 135.97M 10.81M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Sartorius EUR 161.8M 24.4M 2025-06
Sino Biopharmaceutical CNY 1.33B 2.53B 2024-12
Takeda JPY 184.56B 259.5B 2025-06
Tilray USD -42218000 5.65M 2024-11
Zz Pientze Pharmaceu 553.87M 632.12M 2025-06


Tectonic Therapeutic Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.